Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 – 2017)

Publisher Name :
Date: 18-Jan-2013
No. of pages: 896

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, epigenetics offers a potential opportunity in understanding the basis of various diseases in a different approach. Thus, epigenetics is study of heritable changes in genome function and gene expression had opened the new gate of biology to understand the basis of diseases and presents incredible opportunities for disease diagnosis and drug discovery.

Report covers the market by therapeutics sector in oncology conditions, non-oncology indications and personalized medicine. The report also covers the market by research and diagnostics sector in gene regulation studies, biomarker detection and drug discovery. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Epigenetics market is showing a double digit growth (CAGR 25%) due to supportive factors such as, (i) huge amount of funds and investments, (ii) increasing partnerships and collaborations, and (iii) rapid screening tools. Epigenetics is used in the identification of new epigenetic biomarkers, which will aid in better diagnosis and prognosis of diseases. While there are factors favoring the market growth, there are concerns such as change in re-imbursement systems and lack of predictive markers holding back the growth of this market. However, the positive aspects in this field may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: CH3 BioSystems (U.S.), Eisai (Japan), Covaris Inc. (U.S.), Epiontis (Germany), RiboMed Biotechnologies (U.S.), 4SC (Germany), Novus Biologicals (U.S.), Merck Millipore (U.S.), CellCentric (U.K.), Celgene (U.S.), Karus Therapeutics (U.K.), EpiTherapeutics (Denmark), Resverlogix (Canada), Epizyme (U.S.), Glaxosmithkline (U.K.), Epigenomics (Germany).

Scope of the Report

  • This technology report categorizes the market for epigenetics by geographical region (including the important countries in each region), applications, and epigenetic mechanisms, forecasting the market value in revenue by analyzing the current and future trends in research, diagnostics and therapeutics industries.
  • A detailed description of the global technology developments and evolving trends in the epigenetics field with key prominence on research innovations, collaborative efforts and focused research through consortiums dedicated for epigenetics.
  • A close view on the drug development for treatment of various diseases by providing the details and status of current epigenetic drugs in pipeline.
  • An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of epigenetics market during the period from 2012 to 2017.
  • Market size – Global market forecast for 2012-2017, including demand side analysis and strategic recommendations for technology/product developers.
  • Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.

Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 – 2017)

Table of Contents

1 Introduction
1.1 Key Take-Aways
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data Points From Primary And Secondary Sources

2 Executive Summary

3 Epigenetics – Technology Landscape Analysis
3.1 Technology Overview
3.2 Technology Evolution – Milestones In Epigenetics
3.3 Epigenetic Mechanisms
3.3.1 DNA Methylation
3.3.2 Histone Modifications
3.3.3 RNA Interference
3.4 Technology Value Chain Analysis
3.5 Applications
3.5.1 Therapeutics Oncology Conditions Non-Oncology Indications Personalized Medicine
3.5.2 Research And Diagnostics Gene Regulation Studies Biomarker Detection Drug Discovery
3.6 Epigenetics – Technology Innovations And Products With Applications
3.7 Current Scenario In Epigenetics

4 Epigenetics – Market Landscape Analysis
4.1 Epigenetics Market Size – Potential Addressable Market
4.2 Global Epigenetics Market Segmentation
4.3 Global Market Revenue Forecast (2012-2017)
4.3.1 By Geography
4.3.2 By Applications
4.3.3 By Epigenetic Mechanisms
4.4 Market Share of Companies
4.5 Market Dynamics
4.5.1 Drivers
4.5.2 Restraints
4.5.3 Challenges

5 Technology Investment Potential
5.1 Investor Network
5.1.1 Some Funds And Investments By Public Funding Bodies
5.1.2 Some Funds And Investments By Non-Government Organizations (Ngos)
5.1.3 Some Investments By Corporate, Private And Equity Investors
5.1.4 Insights on Current And Future Tech-Investment Trends
5.1.5 Funding Patterns And Investor Inclination
5.2 Investment Opportunities
5.2.1 Epigenetic Technologies And Products Available For Licensing & Acquisition For Stakeholders
5.2.2 Analysis of Potential Application Areas For Technology Investment – Based On Opportunity Strategy Evaluation (OSE) Analysis

6 Epigenetics – Technology Adoption Potential And Development By Geography
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia
6.5 Row
6.6 Demand Side Analysis

7 Epigenetics Competitive Landscape
7.1 Key Mergers And Acquisitions
7.2 Partnerships And Collaborations
7.3 Therapeutic Drugs In Pipeline
7.4 Worldwide Consortiums And Networks In Epigenetics

8 Intellectual Property And Research Strength Analysis
8.1 Ip Strength Analysis of Epigenetics Between 2008-2012
8.2 Analysis of Research Strength From Ncbi Pubmed Publications

9 Analyst Insights And Recommendations
9.1 Analyst Insights
9.2 Analyst Recommendations
9.3 Open Opportunity Invitations In The Field For Business Development

10 Company Profiles
10.1 4sc (Germany)
10.2 Celgene (U.S.)
10.3 Cellcentric (U.K.)
10.4 Ch3 Biosystems (U.S.)
10.5 Covaris Inc (U.S.)
10.6 Eisai Co Ltd (Japan)
10.7 Epiontis (Germany)
10.8 Epitherapeutics (Denmark)
10.9 Epizyme (U.S.)
10.10 Karus Therapeutics (U.K.)
10.11 Merck Millipore (U.S.)
10.12 Ribomed Biotechnologies (U.S.)

11 Appendix

12 Glossary

List of Tables

Table 1 Global Epigenetics Market Revenue, By Geography, 2012–2017 ($Million)
Table 2 Global Epigenetics Market Revenue, By Application Segments, 2012–2017 ($Million)
Table 3 Global Epigenetics Market Revenue, By Therapeutic Applications, 2012–2017 ($Million)
Table 4 Global Epigenetics Market Revenue, By Research & Diagnostics Applications, 2012–2017 ($Million)
Table 5 Global Epigenetics Market Revenue, By Epigenetic Mechanisms, 2012–2017 ($Million)
Table 6 Market Share of Companies Based On Currently Available Four Drugs
Table 7 Some Funds And Investments By Public Funding Bodies
Table 8 Epidemiology And Genomics Research Program (Egrp) Funding Details For Epigenetics
Table 9 Nih Funding Details For Epigenetics
Table 10 Some Funds And Investments By Non-Government Organizations (Ngos)
Table 11 Some Investments By Corporate, Private And Equity Investors
Table 12 Worldwide Incidence & Mortality of Selected Cancers (Cases/Year)
Table 13 Mergers And Acquisitions
Table 14 Partnerships And Collaborations
Table 15 Therapeutic Drugs In Pipeline
Table 16 Key Patents
Table 17 Different Types of Products For Epigenetic Mechanisms – Dna Methylation
Table 18 Different Types of Products For Epigenetic Mechanisms – Histone Modifications
Table 19 Different Types of Products For Epigenetic Mechanisms – Rna Interference

List of Figures

Fig 1 Global Market of Epigenetics 2012–2017 ($Million)
Fig 2 Global Epigenetics Market Revenue, By Geography, 2012–2017 ($Million)
Fig 3 Global Epigenetics Market Share – By Geography
Fig 4 Global Epigenetics Market Revenue, By Application Segments,2012-2017 ($Million)
Fig 5 Global Epigenetics Market Revenue, By Therapeutic Applications, 2012–2017 ($Million)
Fig 6 Global Epigenetics Market Revenue, By Research & Diagnostics Applications, 2012–2017 ($Million)
Fig 7 Global Epigenetics Market Share – By Applications
Fig 8 Global Epigenetics Market Revenue, By Epigenetic Mechanisms, 2012–2017 ($Million)
Fig 9 Market Share of Companies Based on Currently Available Four Drugs
Fig 10 Epidemiology And Genomics Research Program (Egrp) Funding Details For Epigenetics
Fig 11 Nih Funding Details For Epigenetics
Fig 12 Epigenetics, Year-Wise Funding Patterns & Investment Forecast (2012–2017)
Fig 13 Current FundingPattern By Investors For Epigenetics
Fig 14 Patents Published Between 2008-2012
Fig 15 Pubmed Publications Between 2008-2012
Fig 16 Pubmed Publications on Epigenetic Enzymes 2008-2012

  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Growth in the Indian Watch Industry
    Earlier, in India watches were seen as a luxury item. However, watches are now witnessing a fundamental change in perception, and are now gaining respect as an essential utility item. With the liberalization of the Indian market, coupled with the rising purchasing power of the young and consumerist Indians, watch industry in India seems to [...]
  • Global Retail Ready Packaging Market to Witness Steady Growth
    The market for retail ready packaging has witnessed impressive growth in recent years with boom in the retail industry. Retail ready packaging, also known as shelf-ready packaging is designed for the retail outlet, ready to be placed on shelf without any need for unpacking or repacking. In 2011, the global market for retail packaging was [...]
  • Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) – Global Forecasts to 2018
    Published: 17-Apr-2014        Price: US $4650 Onwards        Pages: 270
    The global flow cytometry market is estimated to grow at a lower CAGR in developed countries; however it is expected to witness a high growth in the emerging countries such as China, India, and Brazil. Factors such as the technological advancements in flow cytometry instruments; fostering research activities in the field of life sciences such as proteomics, genomics, and pharmacogenomics; growing clinical trials; fostering prevalence of HIV and cancer; launch of new reagents for specific applica......
  • Food Diagnostics Systems Market [By Type (Hybridization, Chromatography, Spectrometry, Biosensor, Immunoassay, Testing Kit)], Consumables Market [By Type (Reagents, Disinfectants, Test Accessories)] & By Geography – Global Trends & Forecast To 2018
    Published: 16-Apr-2014        Price: US $4650 Onwards        Pages: 290
    The food diagnostics market size is projected to increase with rising concerns over food quality and safety, and the implementation of stringent regulations on food safety and foodborne illness prevention. Globalization of food trade has further extended the scope for the food diagnostics market. The emerging markets with increasing demand for food testing are estimated to generate potential opportunities in the market. The food diagnostics market was sub-segmented into diagnostic systems and......
  • 2014 Deep Research Report on Global and China H acid Industry
    Published: 16-Apr-2014        Price: US $2200 Onwards        Pages: 149
    This is a professional and depth research report on Global and China H acid industry. The report firstly introduced H acid basic information included H acid definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, H acid industry policy and plan, H acid product specification, manufacturing process, product cost structure etc. then statis......
  • Fluid Management & Visualization Systems Market by Product (Suction & Irrigation, Dialyzer, Fluid Warming & Waste Management, Endoscopic Camera, Tubing’s, Bloodlines), & Application (GI, Urology, Arthroscopy, Gynecology) – Global Forecasts to 2018
    Published: 16-Apr-2014        Price: US $4650 Onwards        Pages: 360
    The fluid management and visualization systems industry has evolved from traditional standalone systems to modern automated, integrated systems to increase the endosurgical procedure outcomes. Patient safety and security from infections have also gained greater importance in fluid management and visualization systems over the years. Over the past few years, the fluid management and visualization systems market has witnessed a stable growth. The market is expected to grow at a CAGR of 6.1% fro......
  • Bahrain Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 101
    BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health Regulatory Authority to significantly reduce medicine prices in the country, signalling a potential advancement towards the implementation of a unified Gulf Cooperation Council pricing system. Although less optimistic than before, our medium- and long-term outlooks for the Bahrain pharmaceutical market remain bullish. Medicines uptake will be supported by robust economic growth, in addition to the country......
  • Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 65
    BMI View: Low health and pharmaceutical expenditures will continue to limit the attractiveness of the pharmaceutical market in Cambodia. Given such a profile, the country will present more commercial benefits to companies dealing with inexpensive generic drugs and over-the-counter products than innovative pharmaceuticals. Headline Expenditure Projections ? Pharmaceuticals: KHR828.7bn (US$210mn) in 2013 to KHR921.9bn (US$230mn) in 2014; +11.2% in local currency terms and +11.8% in US dollar terms......
  • Czech Republic Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 104
    BMI View: Overall, the Czech healthcare system is facing severe challenges as it struggles to contain budget deficits. At the same time, demand for the latest pharmaceuticals and access to healthcare services is expected to continue its steady growth trajectory, putting pressure on the state and insurers to raise premiums or redistribute funding. Following the release of pharmaceutical sales data by the SUKL, we have significantly revised down historical values for 2013 and forecasts from 2014 o......
  • Denmark Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 60
    BMI View: Although Denmark's pharmaceutical market is relatively small compared to other Western European countries, the demand for high quality healthcare will remain elevated by an increasing and ageing population. This demand could provide opportunities for private healthcare providers to expand as the government continues its restructuring and cost containment measures across the public healthcare sector. Headline Expenditure Projections ? Pharmaceuticals: DKK20.20bn (US$3.58bn) in 2013 to D......
  • Iraq Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 75
    BMI View: The projected growth of Iraq's pharmaceutical market in 2014 and 2015 is linked to an oildriven economic expansion, which is dependent on the government's ability to represent and appease the country's factions. Given the government's expansionary fiscal policy, spending on education, health and public services will be elevated over the coming quarters. In particular, Baghdad will seek to modernise healthcare provision, in a view to improve support to its rule. Nevertheless, there are ......
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs